Sero-prevalence study of parasitic infections among HIV positive and Negative patients in Lagos, Nigeria

Autor: OS Badaru, Adekunle Sanyaolu, NC Iriemenam, WA Oyibo

Publikováno v: African Journal of Clinical and Experimental Microbiology; Vol 17, No 2 (2016); 88-96

Background: Diseases caused by opportunistic pathogens are the major clinical signs of HIV infected and AIDS patients with parasitic infection being part of the common causes of morbidity and mortality. Objectives: This was a cross-sectional study to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1eea243ba0d3b0f5887013a6597cb1
https://doi.org/10.4314/ajcem.v17i2.3

SARS-CoV-2 Serologic Surveillance Among People Living with HIV in Nigeria, April 2022-January 2023.

Autor: Chun HM; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Electronic address: vgi2@cdc.gov., Osawe S; Institute of Human Virology, Abuja, FCT, Nigeria., Adams-Dabban S; Institute of Human Virology, Abuja, FCT, Nigeria., Favaloro J; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Iriemenam NC; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Dirlikov E; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention Mozambique, Maputo, Mozambique., Martin D; Division of Parasitic Diseases and Malaria, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia., Milligan K; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Peraton Inc., Herndon, VA, USA., Abutu A; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Okunoye O; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Okoli M; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Akanbi O; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Akinmulero O; Institute of Human Virology, Abuja, FCT, Nigeria., Okonkwo R; Institute of Human Virology, Abuja, FCT, Nigeria., Oyedele O; Institute of Human Virology, Abuja, FCT, Nigeria., Greby S; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Abimiku A; Institute of Human Virology, Abuja, FCT, Nigeria., Okoye MIJ; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Shiraishi RW; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adegoke D; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Bello M; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Villeng F; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Item II; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Gabo S; Nigeria Centre for Disease Control and Prevention, Abuja, FCT, Nigeria., Abubakar A; Institute of Human Virology, Abuja, FCT, Nigeria., Thomas A; Institute of Human Virology, Abuja, FCT, Nigeria., Olaleye T; Institute of Human Virology, Abuja, FCT, Nigeria., Awala S; Institute of Human Virology, Abuja, FCT, Nigeria., Nwatu F; Institute of Human Virology, Abuja, FCT, Nigeria., Ugboaja B; Institute of Human Virology, Abuja, FCT, Nigeria., Udoh I; Institute of Human Virology, Abuja, FCT, Nigeria., Akayi L; Institute of Human Virology, Abuja, FCT, Nigeria., Dattijo J; Institute of Human Virology, Abuja, FCT, Nigeria., Adenekan T; Institute of Human Virology, Abuja, FCT, Nigeria., Aminu-Alhaji A; Division of Global Health Protection, US Centers for Disease Control and Prevention Abuja, FCT, Nigeria., Ezeuko I; Division of Global HIV & Tuberculosis, Global Health Center, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Nov 21, pp. 107309. Date of Electronic Publication: 2024 Nov 21.

Lessons learnt from assessing and improving accuracy and positive predictive value of the national HIV testing algorithm in Nigeria.

Autor: Mpamugo AO; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Iriemenam NC; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Bashorun A; National AIDS, Viral Hepatitis, and STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria., Okunoye OO; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Bassey OO; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Onokevbagbe E; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Jelpe T; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Alagi MA; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Meribe C; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Aguolu RE; Department of Research Monitoring and Evaluation, National Agency for the Control of AIDS, Abuja, Nigeria., Nzelu CE; Department of Planning, Research and Statistics, Federal Ministry of Health, Abuja, Nigeria., Bello S; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria.; Department of Epidemiology and Medical Statistics, Faculty of Public Health, College of Medicine, University of Ibadan, Ibadan, Nigeria., Ezra B; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Obioha CA; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Ibrahim BS; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Adedokun O; Center for International Health, Education and Biosecurity, Maryland Global Initiatives Corporation, University of Maryland, Baltimore (UMB), Abuja, Nigeria., Ikpeazu A; National AIDS, Viral Hepatitis, and STIs Control Programme, Federal Ministry of Health, Abuja, Nigeria., Ihekweazu C; Nigeria Centers for Disease Control, Abuja, Nigeria., Croxton T; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States., Adebajo SB; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States., Okoye MIJ; Division of Global HIV and TB, United States Centers for Disease Control and Prevention, Abuja, Nigeria., Abimiku A; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, United States.

Publikováno v: African journal of laboratory medicine [Afr J Lab Med] 2024 Aug 28; Vol. 13 (1), pp. 2339. Date of Electronic Publication: 2024 Aug 28 (Print Publication: 2024).

Dynamics of IgG antibody response against Plasmodium antigens among Nigerian infants and young children.

Autor: Leonard CM; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.; Oak Ridge Institute for Science and Education, U.S. Department of Energy, Oak Ridge, TN, United States., Uhomoibhi P; National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria., Abubakar A; Institute of Human Virology (IHVN), Abuja, Nigeria., Ogunniyi A; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria., Mba N; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria., Greby SM; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Okoye MI; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Iriemenam NC; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria., Ihekweazu C; Nigeria Centre for Disease Control (NCDC), Abuja, Nigeria., Steinhardt L; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States., Rogier E; Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Aug 24; Vol. 14, pp. 1208822. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

Plasmodium falciparum infection prevalence among children aged 6-59 months from independent DHS and HIV surveys: Nigeria, 2018.

Autor: Oviedo A; Malaria Branch, Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, GA, 30029, USA., Abubakar A; Institute of Human Virology Nigeria, Abuja, Nigeria., Uhomoibhi P; National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria., Maire M; US President's Malaria Initiative, Abuja, Nigeria., Inyang U; United States Agency for International Development, Abuja, Nigeria., Audu B; National Malaria Elimination Programme, Federal Ministry of Health, Abuja, Nigeria., Iriemenam NC; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Ogunniyi A; Nigeria Centre for Disease Control, Abuja, Nigeria., Ssekitooleko J; The Global Fund to Fight AIDS, Tuberculosis, and Malaria, Geneva, Switzerland., Kalambo JA; The Global Fund to Fight AIDS, Tuberculosis, and Malaria, Geneva, Switzerland., Greby SM; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Mba N; Nigeria Centre for Disease Control, Abuja, Nigeria., Swaminathan M; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Ihekweazu C; Nigeria Centre for Disease Control, Abuja, Nigeria., Okoye MI; Division of Global HIV and TB, US Centers for Disease Control and Prevention, Abuja, FCT, Nigeria., Rogier E; Malaria Branch, Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, GA, 30029, USA., Steinhardt LC; Malaria Branch, Division of Parasitic Diseases and Malaria, United States Centers for Disease Control and Prevention, Atlanta, GA, 30029, USA. iyp6@cdc.gov.

Publikováno v: Scientific reports [Sci Rep] 2023 Feb 03; Vol. 13 (1), pp. 1998. Date of Electronic Publication: 2023 Feb 03.